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When we consider factors that contribute to the emergence, amplification, and
persistence of antibiotic resistant bacteria, the conventional assumption is that antibiotic
use is the primary driver in these processes and that selection occurs primarily in
the patient or animal. Evidence suggests that this may not always be the case.
Experimental trials show that parenteral administration of a third-generation cephalosporin
(ceftiofur) in cattle has limited or short-term effects on the prevalence of ceftiofur-resistant
bacteria in the gastrointestinal tract. While this response may be sufficient to explain a
pattern of widespread resistance to cephalosporins, approximately two-thirds of ceftiofur
metabolites are excreted in the urine raising the possibility that environmental selection
plays an important additive role in the amplification and maintenance of antibiotic resistant
E. coli on farms. Consequently, we present a rationale for an environmental selection
hypothesis whereby excreted antibiotic residues such as ceftiofur are a significant
contributor to the proliferation of antibiotic resistant bacteria in food animal systems. We
also present a mathematical model of our hypothesized system as a guide for designing
experiments to test this hypothesis. If supported for antibiotics such as ceftiofur, then
there may be new approaches to combat the proliferation of antibiotic resistance beyond
the prudent use mantra.
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INTRODUCTION
Since first being introduced in the 1940’s, antibiotics have
improved or saved the lives of countless millions of people either
directly through disease prevention and treatment, or indirectly
by enabling greater food production capacity. Unfortunately,
antibiotic use of any kind invariably selects for the emergence,
amplification, and persistence of resistant bacteria. The evolu-
tionary dynamics of antibiotic resistance differ depending on how
different resistance traits function. For example, when antibi-
otic resistance involves active efflux or enzymatic degradation
pathways, we might expect longer periods to elapse between
the introduction of a new antibiotic and adaptation of resis-
tance mechanisms. Of course, naturally produced antibiotics
have been selecting for emergence of resistance mechanisms as
long as antibiotics have existed in nature (Allen et al., 2010).
Consequently, if resistance mechanisms exist, these toolboxes will
eventually be co-opted by pathogens. In contrast, antibiotics such
as rifamycins, quinolones, and fluoroquinolones bind specific
proteins where simple chromosomal mutations are sufficient to
alter the binding sites and produce clinically relevant resistance.
Acquisition of these mutations can occur during antibiotic expo-
sure, and resistant organisms can subsequently sweep through
populations that experience drug selection pressure (Humphrey
et al., 2005). Despite the relative ease with which these chro-
mosomal mutations can arise for quinolones, and by extension
fluoroquinolones, more complex resistance mechanisms of resis-
tance have already been documented in the field (Xia et al.,
2010).
There are several strategies to address the challenge of antibi-
otic resistance with introduction of new antibiotics being an
important avenue in the past 50 years. Aside from the multi-
tude of challenges that now limit development of new antibiotic
products (Spellberg et al., 2008), there are fewer completely novel
antibiotics being developed and thus we can expect less time to
pass between introduction of new products and emergence of
widespread antibiotic resistance. For example, a recent review
identified 20 new antibiotics that are currently working through
product development pipelines (Butler and Cooper, 2011). Of
these, 9 are synthetic compounds and 8 of these are quinolones
for which we can predict relatively rapid emergence of resistance.
Consequently, it is unlikely that we will stay ahead of this problem
in the future through new drug development alone.
“Prudent use” is an important policy-based strategy to com-
bat the growing antibiotic resistance challenge by ensuring that
antibiotics are only used when they are actually needed, that
the most appropriate antibiotic is used for a given disease agent,
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and that exacting dosage guidelines are followed (Gyssens, 2011).
While emergence of antibiotic resistance is inevitable, prudent
use practices are likely to limit the overall level of drug selec-
tion pressure and consequently limit the equilibrium prevalence
of resistant pathogens (Austin et al., 1999). Greater attention to
biosecurity and infection prevention measures, use of rapid diag-
nostics, and use of effective vaccines and probiotics should also
reduce disease incidence and thus reduce demand for antibiotics.
Attention to prudent use invariably brings scrutiny to antibi-
otic use practices in food animal production. From a “mass-
action” perspective, more antibiotics are used in food animal
production than in humanmedicine and consequently this sector
may contribute disproportionately to development of antibiotic
resistance (Sarmah et al., 2006). In the U.S. an estimated 3.3 mil-
lion kg of antibiotics were sold for human use in 2010 (FDA,
2012b) while 12.2 million kg (FDA, 2011) were sold for use in
food animal applications. There are a number of reasons why
we should be cautious about directly comparing these num-
bers (FDA, 2012a), but it is important to note that monensins
account for 28.9% of the total sales for use in food animals. These
ionophores are entirely unique from antibiotics that are used in
people and they function by transporting ions across bacterial cell
membranes thereby disrupting ion gradients and killing suscep-
tible bacteria (Callaway et al., 2003). Resistance to monensins has
been suggested, but it is not clear if this is a function of intrinsi-
cally resistant populations dominating in a community exposed
to monensins, or due to emergence of novel resistance mecha-
nisms. To date, no genetically-encoded, horizontally transmissible
resistance traits have been described for monensins (Callaway
et al., 2003) and there is no recognized means by which use of
monensins contribute to selection for other antibiotic resistance
traits in pathogenic or commensal bacteria.
The largest component of antibiotic sales for food animals
includes oxytetracycline and chlortetracycline (42.2%) (FDA,
2011) and these are mostly used as in-feed additives to promote
animal health and growth. It could be argued that because tetracy-
clines make-up a relatively small percentage of demand in human
medicine (3.9%) (FDA, 2012a), resistance to these drugs has a
limited potential to impact human health and thus these com-
pounds are a “good” choice relative to other options that might be
employed. An important caveat to this conclusion is that tetracy-
cline resistance is commonly associated with multidrug resistant
bacteria (FDA, 2012c) and thus selection that favors tetracycline
resistance will also co-select for other genetically-linked antibiotic
resistance traits. Co-selection of this nature has been described for
other antibiotics and toxins such as heavy metals (Stepanauskas
et al., 2006; Tremblay et al., 2012).
The therapeutic use of veterinary antibiotics, while represent-
ing a lower total mass of antibiotics, is also heavily scrutinized
as a contributor to the antibiotic resistance crisis. In the U.S.
this is probably best exemplified by fluoroquinolone use in poul-
try production. Flock-wide treatment (metaphylactic) with an
antibiotic such as enrofloxacin (veterinary antibiotic) exerts selec-
tive pressure for resistance to the antibiotic ciprofloxacin (human
antibiotic) in Campylobacter jejuni, which is a non-target bac-
terium in this application. Because simple chromosomal muta-
tions quickly lead to ciprofloxacin resistance and because poultry
is a major reservoir for transmission of C. jejuni to people, fluo-
roquinolones are no longer approved for use as a metaphylactic
treatment via poultry water (FDA, 2005). Unfortunately, despite
this withdrawal in 2005, the prevalence of ciprofloxacin resistant
C. jejuni has remained >20% by 2010 for poultry and human
clinical isolates alike in the U.S. (FDA, 2012c). It is unclear if this
persistence is due to alternative exposure routes or due to resis-
tant strains disseminating via food and travel. Some mutations
that convey resistance to ciprofloxacin might also be fitness neu-
tral or they might convey a fitness advantage to the bacteria. If
so, the prevalence of ciprofloxacin resistant C. jejuni is unlikely to
decrease significantly even after cessation of enrofloxacin use in
poultry medicine (Luo et al., 2005).
Another important therapeutic antibiotic in production
medicine is ceftiofur. This third-generation cephalosporin is
widely used as an injectable antibiotic to treat respiratory infec-
tions, metritis, and pododermatitis in cattle, but it has also been
used in swine, small ruminants, and poultry. Ceftiofur gained
rapid acceptance since the 1990’s, particularly in the dairy sec-
tor (Zwald et al., 2004; Sawant et al., 2005; Sarmah et al., 2006;
Saini et al., 2012) because it is a very effective antibiotic with
no withholding time for milk production. Nevertheless, increas-
ing resistance to third-generation cephalosporins in Salmonella
recently led the US Food and Drug Administration to adopt new
rules banning non-therapeutic and extra-label uses of this impor-
tant veterinary antibiotic (FDA, 2012d). There is debate as to
whether or not these regulatory changes will have a significant
impact on use practices (Wittum, 2012), and as we outline below
these changes are likely to have little impact on the amplification
of resistant enteric bacteria if amplification of resistant popula-
tions is primarily driven by excreted ceftiofur metabolites in the
environment.
ENVIRONMENTAL FATE OF ANTIBIOTICS
Ceftiofur poses an interesting conundrum because while resis-
tance is prevalent in E. coli and Salmonella in the U.S. (Winokur
et al., 2000; Donaldson et al., 2006; Daniels et al., 2007, 2009;
Sawant et al., 2007; Heider et al., 2009; Lindsey et al., 2009),
empirical studies show either no treatment effect (Singer et al.,
2008; Daniels et al., 2009; Mann et al., 2011) or transient and
relatively short-term amplification of resistant populations (Jiang
et al., 2006; Lowrance et al., 2007) after administration of ceftio-
fur. Lowrance et al. (2007) provided themost convincing evidence
that selection occurs in the gastrointestinal tract where there
was a proportional increase in the number of ceftiofur-resistant
E. coli following 1, 2, or 3 days administration of a ceftiofur
crystalline-free acid product. This study included 61 feedlot steers
and resistant E. coli were found between 1 and 2 log higher den-
sities compared with control animals, and the effects lasted ∼2
weeks. Two-weeks might be considered a relatively short-term
impact because it is also consistent with a failure of survey stud-
ies to find a relationship between the percentage of cows with
ceftiofur-resistant E. coli and the percentage of cows treated at
the herd level (Tragesser et al., 2006; Daniels et al., 2009; Heider
et al., 2009). Jiang et al. (2006) reported an ∼0.5 log increase in
the number of ceftiofur-resistant E. coli immediately following
treatment of three calves with a ceftiofur hydrochloride product.
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In contrast, Mann et al. (2011) reported no significant effects
on the proportion of ceftiofur-resistant E. coli after adminis-
tration of a ceftiofur hydrochloride product (n = 42 animals).
Singer et al. (2008) also reported no change in the number of
ceftiofur resistant E. coli (n = 10 animals). These latter studies
did report a significant decrease in total E. coli following ceftio-
fur administration. Thus, if ceftiofur administration impacts the
intestinal flora, amplification of ceftiofur-resistant E. coli pop-
ulations is variable with outcomes ranging from no detectable
effect to 1–2 log increases probably depending, in part, on the
dose (e.g., 2.2mg/kg vs. 6.6mg/kg) and number of sequential
treatments.
Given the inconsistent and relatively short-term effects of cef-
tiofur treatment on E. coli populations in the gut, this raises
the question of whether selection in vivo represents the entire
story. For example, resistant strainsmay be originating from other
sources and are being transported to cattle via feed or water sup-
plies. Until recently (FDA, 2012d), ceftiofur could be used as an
intramammary prophylactic treatment and this practice has been
associated with an increased prevalence of ceftiofur-resistant fecal
coliform bacteria (Mollenkopf et al., 2010). The authors of this
latter study noted that we normally would not expect local admin-
istration of an antibiotic in cow udder to affect enteric flora,
but the authors proposed that amplification of resistant bacte-
ria and subsequent shedding into the environment and contact
transmission could explain this result. In a similar manner, resis-
tant populations of bacteria such as E. coli could be exposed to
antibiotic residues in urine and feces resulting in selective ampli-
fication of the resistant populations in the environment with a
subsequent increased risk of contact-dependent transmission and
colonization of livestock with resistant E. coli.
For an environmental selection process to be important a suf-
ficient concentration of biologically active compound must be
present for a sufficient duration to impact the bacterial com-
munity. Furthermore, animals exposed to higher densities of
resistant bacteria must be at a greater risk of contact transmis-
sion and, ultimately, the resistant bacteria must colonize new
hosts. Environmental surveillance studies have typically reported
that the concentration of antibiotic residues in soil and water
varies between parts per trillion (ppt) and parts per billion
(ppb) (Winokur et al., 2000; Tolls, 2001; Koplin et al., 2002;
Thiele-Bruhn, 2003; Sawant et al., 2007; Ji et al., 2012); values typ-
ically well below the concentration needed (ppm) to demonstrate
effects from antibiotics in vitro. There is speculation that bacteria
could be impacted by additive or synergistic effects or that non-
target organisms could be impacted at very low concentrations,
but with the exception of possible effects on algae there is little
evidence that ppt and ppb concentrations of antibiotics have any
impact in the environment (Ji et al., 2012).
Another way to address this question is to mix combinations
of antibiotics at low doses and determine if there is an addi-
tive or synergistic effect. Using a simple experiment we show
here that there is no evidence for inhibition of bacterial growth
in vitro until the antibiotics being used reach a concentration
where we should expect inhibition of a sensitive strain (i.e., ppm)
(Figure 1). There is also reason to expect that any subtle addi-
tive or synergistic effects on fitness will be even less prominent in
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FIGURE 1 | Antibiotic residues only affect bacteria from a fitness
standpoint when the concentration of residue approaches a minimum
inhibitory concentration (MIC). MIC values are typically >1ppm, whereas
most environmental residue reported in the literature are found at ppb or
ppt. These might be significant if there is an additive or synergistic effect
attributed to exposure to multiple low-dose antibiotic residues. In this
example, single antibiotics and a mixture of four antibiotics at the same
concentration were tested against a sensitive strain of E. coli (K-12). The
response to the mixture is most closely associated with ceftiofur
(r2 = 0.999). If there was an additive or synergistic effect on fitness we
would expect to see the mixed antibiotic (solid square) as having the lowest
optical density at 100ppb, which is not the case in this experiment. Each
data point represents the optical density after 24h growth in LB as
measured using a Bioscreen plate reader. Average for three independent
replicates is shown.
the environment where bacteria typically reside within biofilms
that are recalcitrant to antibiotics (Lewis, 2007) and where
antibiotic bioavailability may be compromised (Subbiah et al.,
2011).
Studies of environmental residues typically measure antibi-
otics using analytic tools such as ELISA, HPLC, and mass spec-
trometry (Koplin et al., 2002; Sczesny et al., 2003; Thiele-Bruhn,
2003; Kumar et al., 2004; Aga et al., 2005; Berendsen et al., 2012);
methods that can be exquisitely well-suited for detecting mini-
mal concentrations of antibiotics, but these methods do not tell
us if the antibiotic residues being detected are biologically avail-
able. To be biologically available, antibiotics need to be physically
available to interact with target cells. Antibiotics such as tetra-
cyclines, however, are known to rapidly adsorb to clay surfaces
(Tolls, 2001) rendering them unavailable to exert biological effects
in soils. Subbiah et al. (2011) explored this process further bymix-
ing high concentrations of antibiotics (200 ppm) with soil slurries
that differed in clay content, pH and other properties. After mix-
ing, supernatant was recovered, filter sterilized, and added to a
broth culture of an antibiotic sensitive E. coli strain. If the strain
grew, this indicated that there was an insufficient concentration
of antibiotic in the liquid phase to have any impact on the test
strain because the antibiotic had adsorbed to the soil materials.
Using this assay, tetracycline, neomycin, and ciprofloxacin had
no effect on bacterial growth after mixing with sand-loam and
silt-loam soils; tetracycline, ciprofloxacin, and two sulfonamide
antibiotics retained at least partial activity in sand. Even when
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antibiotic sensitive E. coli were added to a viscous soil slurry with
adsorbed tetracycline, there was no evidence of an impact on fit-
ness (Subbiah et al., 2011). Florfenicol and β-lactams, however,
were mostly available in the liquid phase and these antibiotics
still affected the test bacteria. These results are mostly consis-
tent with what could be predicted from the organic normalized
dissociation constants (Koc) for these compounds (Table 1). Koc
provides an imperfect prediction of how tightly antibiotics adsorb
to soil (Tolls, 2001), but at the extremes tetracycline adsorbs very
tightly (Koc > 420, 999) while florfenicol and sulfadiazine adsorb
very weakly (Koc < 38 and 61, respectively). Ceftiofur is consid-
ered slightly mobile by this measure (Table 1), but ceftiofur may
exist as an anion in soils and this would increase mobility thus
biological availability.
In a subsequent study Subbiah et al. (2012) focused on the fate
of ceftiofur metabolites in soils. When injected into cattle, ceftio-
fur is rapidly metabolized with most of the metabolite being bio-
logically active desfuroylceftiofur (Hornish and Kotarski, 2002).
Jaglan et al. (1989) estimated that 70 and 30% of the metabolites
are then excreted through urine and feces, respectively. Ceftiofur
metabolites are mostly excreted within 24 h and the concentra-
tion varies between ∼7 and 160 ppm in the urine (El-Gendy et al.,
2007; Subbiah et al., 2012); values well within the range needed to
affect sensitive bacteria in vitro. When urine containing ceftiofur
metabolites was added to a soil:feces microcosm (25:1), inhibition
from the antibiotic was evident for 3 days at room temperature.
Table 1 | Sorption coefficients and expected mobility for select
antibiotics in the environment.
Antibiotic Class Koc1 Mobility2
Trimethoprim 2,4-diamino
pyrimidine
Median 2589 Slightly mobile
Ampicillin β-lactam 2728 Slightly mobile
Ceftiofur β-lactam 3700 Slightly mobile
Penicillin G β-lactam N.A. Slightly mobile3
Neomycin Aminoglycoside N.A. Non-mobile?
Ciprofloxacin Fluoroquinolone 61,000 Non-mobile
Enrofloxacin Fluoroquinolone Median 99,975 Non-mobile
Lincomycin Macrolide 111 Moderately
mobile
Tylosin Macrolide Median 1264 Slightly mobile
Florfenicol Amphenicols 38 Mobile
Chlortetracycline Tetracycline Median 400,522 Non-mobile
Oxytetracycline Tetracycline Median 47,932 Non-mobile
Tetracycline Tetracycline Median 420,999 Non-mobile
Sulfadiazine Sulphonamide 61 Mobile
1Koc, estimated organic carbon normalized sorption coefficient (L kg−1);
values collated from Sarmah et al. (2006); Pavlovic et al. (2007), and
Metcalfe et al. (2009), and from the Veterinary Substances Database (VSDB,
http://sitem.herts.ac.uk/aeru/vsdb/index.htm).
2Mobility classification, Very mobile (Koc < 15), Mobile (Koc = 15–74),
Moderately mobile (Koc = 75–499), Slightly mobile (Koc = 500–4000), Non-
mobile (Koc > 4000) (Pope et al., 2009).
3Assumed to be similar to other β-lactams.
Biological degradation appeared to explain the loss of the residues
in part because at 4◦C the residues were biologically available up
to 3 weeks from the start of the experiment. Importantly, expo-
sure to urine containing ceftiofur metabolites was sufficient to
produce a log greater increase in growth for a resistant strain of E.
coli compared to the same strain that was exposed to urine with-
out ceftiofur metabolites. Exposure to ceftiofur metabolites in
urine also resulted in >2 month longer retention of the resistant
E. coli strain compared to the same strain in control microcosms.
In the case of ceftiofur, biologically active metabolites are
excreted at a sufficient concentration that remains available to
affect sensitive bacteria in soil. Clearly, the distribution of excreted
residues will be very heterogeneous in a cattle herd depending on
where treated animals urinate and how materials are disturbed
and moved. Furthermore, for this environmental selection sce-
nario to be feasible the amplified populations of resistant E. coli
on the soil surface must present a greater risk of transmission back
to naïve animals compared with conditions where resistant pop-
ulations undergo no selective amplification. Subbiah et al. (2012)
used a controlled experiment to show that bedding contaminated
with a ceftiofur resistant strain of E. coli is sufficient to colo-
nize naïve calves by contact transmission alone, although a wider
range of concentrations and environmental conditions need to
be explored to validate this component of an environmental
selection scenario.
Lowrance et al. (2007) demonstrated a clear in vivo selection
effect from ceftiofur that was dependent on the number injec-
tions of a ceftiofur product (a high dose per injection, 6.6mg/kg
compared to most studies, 2.2mg/kg). Importantly, the untreated
control animals in this study mingled freely with the treated ani-
mals and yet did not show a strong response to the presence of
the treated animals. The control animals were clearly colonized
and apparently they shed a higher concentration at the study
outset (app. 3.5 Log10/g feces) compared to 2 weeks later (app.
3.0 Log10/g feces), but cause and effect for this response is con-
founded, in part, by prior colonization and there was no isolated
control group for comparison. We further surmise that a number
of factors enhance or diminish an environmental effect such as
the season, floor substrate, dose delivered, number of injections,
density of livestock, waste management practices, animal age, and
animal behavior. As a simple example, Lowrance et al. (2007)
studied beef cattle (steers) that probably bed down in contami-
nated substrates less frequently than young calves thereby limiting
an important transmission pathway. If environmental selection
is an important factor in the amplification and persistence of
antibiotic resistant bacteria, and if this process only makes a sig-
nificant contribution under certain environmental conditions,
then it is critical to determine which factors can be modified to
limit selection and transmission as much as possible.
ENVIRONMENTAL SELECTION HYPOTHESIS
Volkova et al. (2012) provided a comprehensive mathematical
model of the dynamics of ceftiofur-sensitive and resistant com-
mensal E. coli in the cow large intestine. This model considered
population size and growth rate in vivo, fitness cost of plas-
mid carriage by resistant bacteria, and the effect of ceftiofur
metabolites in the intestine (entering via bile salts). Volkova and
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colleagues focused on the in vivo selection compartment, but their
model included an “in flow” component from the environment
through which resistant and sensitive bacteria enter the cow. They
concluded, in part, that the rate of replacement E. coli acquired
through ingestion is an important factor when these strains
are ceftiofur resistant. Volkova et al. (2013) explicitly addressed
approaches for controlling plasmid-mediated resistance in enteric
commensal bacteria and their model also includedmultiple path-
ways by which resistant bacteria can be ingested. Our proposed
model focuses on selection in the environment based, in part,
on the fact that approximately two-thirds of biologically active
metabolite after ceftiofur administration is excreted in the urine
and thus may be a significant factor leading to amplification of
resistant bacteria that subsequently enter the Volkova model via
the “in flow” parameter. Notably, neither Volkova et al. (2012)
nor Volkova et al. (2013) considered the effects of excreted
antibiotic in their scenarios. From a “mass action” perspective,
selection in the environment may play a more significant role
in this process. Nonetheless, it is possible that a more accurate
model will be a hybrid of both the in vivo and ex vivo selection
compartments.
We hypothesize that excreted ceftiofur contributes to ampli-
fication and persistence of resistant enteric bacteria in soils,
and consequently use of these antibiotics increases the risk that
resistant bacteria will be transmitted back to cattle (Figure 2).
While our focus is centered on ceftiofur in these discussions, if the
environmental selection hypothesis is valid then it likely applies to
other excreted antibiotics that remain biologically available after
contact with the ground substrate (Subbiah et al., 2011). A math-
ematical representation of this hypothesis can be formulated as
follows:
dSH
dt
= αSE + rSH (1 −
(SH + RH)
KH
)SH − λSH
dRH
dt
= αRE + rRH (1 −
(SH + RH)
KH
)RH − λRH
dSE
dt
= λf SH + rSE (1 −
(SE + RE)
KE
)SE − μSESEX
γ
E
(EC50S)γ + XγE
− αSE
dRE
dt
= λf RH + rRE (1 −
(SE + RE)
KE
)RE − μREREX
γ
E
(EC50R)γ + XγE
−αRE
dXH
dt
= C(t) − δHXH − eXH
dXE
dt
= feXH − δEXE
Decay of anbioc in host at rate δHXH
Growth of suscepble and resistant 
strains at maximal rates rSH and rRH
limited by carrying capacity KH
Decay of anbioc in environment at 
rate δEXE
Growth of suscepble and resistant 
strains at maximal rates rSE and rRE
limited by carrying capacity KE
Death of suscepble and resistant strains 
in presence of anbioc with respecve 
maximal kill rates μSE and μRE and half 
maximal eﬀecve concentraons of EC50S
and EC50R
Host
Inﬂow of suscepble
and resistant strains from 
environment into host at 
rates αSE and αRE
Oulow of suscepble
and resistant strains from 
host to environment at 
rates λSH and λRH of which 
a proporon f is excreted 
into the urine 
contaminated 
environment.
Oulow of anbioc from 
host at rate eXH
of which a proporon f is 
excreted into the urine 
contaminated environment.
Treatment of host with 
anbioc at rate C(t)
Urine contaminated environment
FIGURE 2 | Graphical depiction of the environmental selection
hypothesis by which excreted antibiotic metabolites selectively
amplify resistant bacteria in the environment. Amplification of
resistant bacteria subsequently increases the probability of
transmission back to the host. See text for details about model
parameters.
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where SH and RH represent susceptible and resistant strains in
the host, and SE and RE represent susceptible and resistant strains
in the urine contaminated environment, respectively. We are ini-
tially assuming that there is no selection by ceftiofur in the host,
that the host population ingests bacteria from the environment
at a rate α and excretes bacteria into the whole environment at
rate λ, and that a proportion f of bacteria is excreted into areas
contaminated with urine.
Within the host, the net replication rate of the strains is given
by rSH and rRH , and the total size of the resistant and suscepti-
ble population is limited by a carrying capacity KH . Within the
urine contaminated environment, the dynamics of the susceptible
and resistant populations are similarly dependent on the inges-
tion and excretion of strains by the host and by growth that is
limited by a carrying capacity KE. If in vivo selection proves to be
a more significant selection factor than we presume based on the
literature, then an in vivo selection parameter can be added to the
model.
In addition, the dynamics in the urine contaminated environ-
ment also include terms that capture antibiotic induced death
of the resistant and susceptible strains, where μSE and μRE are
the maximal kill rates, XE, the concentration of antibiotic in the
environment, γ the Hill coefficient, and EC50S and EC50R the half
maximal effective concentration for the susceptible and resistant
strains, respectively (Vinks, 2002). The concentration of antibi-
otic in the host is determined by a treatment rate, C(t), a decay
rate in the host, δH , and an excretion rate into the environment, e.
To test the environmental selection hypothesis for ceftiofur
we propose to compare the rates of acquisition of resistance
among calves in groups including both ceftiofur treated and
untreated animals. The calves would initially be presumptively
free of ceftiofur-resistant E. coli and they would be introduced
into an environment where ceftiofur resistant E. coli are present.
We propose to then compare acquisition rates in groups that dif-
fer in the proportions of treated animals. Our hypothesis predicts
a more rapid acquisition of resistant strains in groups with a
higher proportion of treated animals because greater excretion
of ceftiofur will allow greater environmental selection, but no
difference between the treated and untreated animals within a
group. Specifically, by monitoring animals for colonization, we
can obtain estimates for αRE, the rate of acquisition of resistant
strains, and compare these estimates between groups and between
treated and untreated animals. Additionally, comparing environ-
mental concentrations of resistant strains between groups with
high and low proportions of treated animals, and relating these
concentrations to acquisition rates, would enable us to estimate
the uptake parameter α.
Volkova et al. (2012) describes the mechanism by which resis-
tance may persist within the host via plasmid mediated transfer,
whilst the model of Volkova et al. (2013) additionally captures
plasmid-mediated transfer in the environment. Our goal, how-
ever, is to specifically assess whether environmental selection of
strains in the presence of ceftiofur is a more important source of
resistance acquisition than within host selection.
CONCLUSION
Antibiotic resistance is an increasing challenge to public health
worldwide. Currently, our only tools to combat this challenge
include developing new antibiotics and preserving the utility of
existing antibiotics as long as possible through prudent use prin-
ciples. Our work suggests that blocking environmental selection
could be another important avenue to combat resistance to some
antibiotics that are used in food animal medicine. If environmen-
tal selection proves to be a significant contributor to maintenance
of antibiotic resistance for drugs like ceftiofur (e.g., florfeni-
col), then it is likely that management and engineered solutions
can be devised to limit this component of the selection prob-
lem. Importantly, by finding solutions to address unappreciated
components of the selection process such as the one described
here, it should be possible to extend the utility of important
drugs like ceftiofur for use in food animal production. Doing so
benefits animal welfare and public health while helping to main-
tain lower costs for producing food for the burgeoning human
population.
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